Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that predominantly affects the optic nerves and spinal cord. Recombinant antibodies (rAbs) generated from clonally expanded plasma cells in an NMO patient are specific to AQP4 and pathogenic. We screened phage-displayed peptide libraries with these rAbs, and identified 14 high affinity linear and conformational peptides. The linear peptides shared sequence homologies with NMO autoantigen AQP4 on the extracellular surface. Competitive inhibition ELISA and immunocytochemistry demonstrated that these peptides represent epitopes of NMO autoantigen AQP4. Peptide epitopes/mimotopes may have potential uses for disease prognosis, monitoring, and therapy.
Introduction
Neuromyelitis optica (NMO) is a severely debilitating autoimmune disease that predominantly attacks the optic nerve and spinal cord causing blindness and paralysis. A diagnostic hallmark of NMO is the presence of serum autoantibodies against AQP4 (AQP4-Ab) in most NMO patients. Prominent IgG and complement deposition in NMO lesions, a paucity of T cells, and beneficial effects of B cell depletion and plasma exchange suggest that the humoral response is important in the pathogenesis of NMO (Lucchinetti et al., 2002; Lennon et al., 2005; Kinoshita et al., 2009; Sabater et al., 2009 ) Furthermore, recent in vivo studies revealed that intracerebral injection of human AQP4-specific autoantibodies and complement produce NMO lesions in mice (Bradl et al., 2009; Saadoun et al., 2010) .
In inflammatory and infectious CNS diseases, CD138 + plasma blasts in CSF are the primary source of intrathecal Ig production (Owens et al., 2007; Cepok et al., 2005 Cepok et al., . 2007 . Using fluorescent activated cell sorting (FACS) and single-cell RT-PCR, we demonstrated the presence of clonally expanded plasma cells in NMO CSF with features of a T cell-dependent, antigen-targeted response. Consistent with the pathogenic role of AQP4 autoantibodies, our findings revealed that an intrathecal humoral immune response against AQP4 is evident at the onset of clinical disease. Furthermore, recombinant antibodies (rAbs) generated from clonally expanded plasma cells in NMO CSF are AQP4-specific and immunopathologic (Bennett et al., 2009) . Herein, using NMO rAbs, we identified high affinity peptides from phage-displayed random peptide libraries, some of which represent epitopes of AQP4. Identification of high affinity peptides of NMO rAbs may improve diagnostics, and will likely determine the immunopathogenesis of disease. In addition, NMO B cell epitopes provide tools as protective epitopes (inhibitors) to compete for binding to pathogenic AQP4-Ab without triggering the complement cascade.
Materials and methods

Generation of NMO recombinant antibody
CD138
+ plasma cell sorting and IgG heavy and light chain variable sequence amplification were performed as described (Ritchie et al., 2004; Bennett et al., 2009 ). All rAbs were constructed and generated as reported (Bennett et al., 2009 ).
Biopanning, phage titration and amplification
PhD.-12™ and PhD C7C Phage Display Peptide Libraries (New England BioLabs, Beverly, MA) were used for affinity selection of specific peptides. Panning was as described (Yu et al., 2006a) except Journal of Neuroimmunology 236 (2011) 65-71 
